Imaging thromboembolism with Tc-99m-labeled thrombospondin receptor analogs TP-1201 and TP-1300

Thrombosis Research

Volumn 93, Issue 4, 1999, Pages 191-202

  Pallela, V R ^a   Thakur, M L ^a   Consigny, P M ^a   Rao, P S ^a   Vasileva Belnikolavska, D ^a   Shi, R ^a  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

Imaging, DVT; Imaging, PE; Tc 99m peptides; Tc 99m TP, 1201; Tc 99m TP, 1300; Tc 99m TSP, analogs

Indexed keywords

BITASTIN I 123; DMP 444 TC 99M; HEXAPEPTIDE; P 280 TC 99M; P 748 TC 99M; RECEPTOR; TECHNETIUM 99M; THROMBOSPONDIN; TP 1201 TC 99M; TP 1300 TC 99M; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; DEEP VEIN THROMBOSIS; DOG; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG STABILITY; HUMAN; HUMAN CELL; ISOTOPE LABELING; LUNG EMBOLISM; NONHUMAN; PLASMA CLEARANCE; PRIORITY JOURNAL; RABBIT; SCINTISCANNING; SWINE; THROMBOCYTE AGGREGATION; THROMBOEMBOLISM;

ANIMALS; ANTIGENS, CD36; HUMANS; PEPTIDE FRAGMENTS; PLATELET AGGREGATION; RABBITS; TECHNETIUM; THROMBOEMBOLISM;

EID: 0033557567     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(98)00180-7     Document Type: Article

References (39)

1. Vital and Health Statistics. Series 13: Data from National Health Survey Ditts Publication (PHS) 1993;95:1783.
2. Koblik P.D., DeNardo G.L., Berger H.J. Current status of immunoscintigraphy in the detection of thrombosis and thromboembolism. Semin Nucl Med. 19(3):1989;221-231.
3. Thakur M.L., Welch M.J., Joist J.H., Coleman R.E. Indium-111 labeled platelets. Studies on preparation and evaluation of in vitro and in vivo functions Thromb Res. 9(4):1976;345-357.
4. Zoghbi S.S., Thakur M.L., Sostman H.D., Neumann R.D., Carbo P., Lord P., Greenspan R.H., Gottschalk A. The influence of heparin on the in vivo distribution of In-111 labeled platelets. Invest Radiol. 20:1985;198-202.
5. Knight L.C. Radiopharmaceuticals for thrombus detection. Semin Nucl Med. 20(1):1990;52-67.
6. Thakur ML. Potential of radiolabeled antiplatelet antibodies in the detection of vascular thrombi. In: Srivastava SC, editor. Radiolabeled Monoclonal Antibodies for Imaging and Therapy. NATO ASI, series 152. Plenum Publishing Co.; 1988.
7. Thakur M.L. Scintigraphic imaging of venous thrombosis. A state of the art Thromb Hematol Disord. 5:1992;29-36.
8. Knight L.C., Radcliffe R., Maurer A.H., Rodwell J.D., Alvarez V.L. Thrombus imaging with technetium-99m synthetic peptides based upon the binding domain of a monoclonal antibody to activated platelets. J Nucl Med. 35(2):1994;282-288.
9. Knight L.C., Maurer A.H., Romano J.E. Comparison of iodine-123-disintegrins for imaging thrombi and emboli in a canine model. J Nucl Med. 37:1996;476-482.
10. Pearson D.A., Lister-James J., McBride W.J., Wilson D.M., Martel L.J., Civitello E.R., Dean R.T. Thrombus imaging using technetium-99m-labeled high-potency GPIIb/IIIa receptor antagonists. Chemistry and initial biological studies. J Med Chem. 39(7):1996;1372-1382.
11. Lister-James J., Vallabhajosula S., Moyer B.R., Pearson D.A., McBride B.J., DeRosch M.A., Bush L.R., Machac J., Dean R.T. Pre-clinical evaluation of technetium-99m platelet receptor-binding peptide. J Nucl Med. 38(1):1997;105-111.
12. Pearson D.A., Lister-James J., McBride W.J., Wilson D.M., Martel L.J., Civitello E.R., Dean R.T. Thrombus imaging using technetium-99m-labeled high-potency GPIIb/IIIa receptor antagonists. Chemistry and initial biological studies J Med Chem. 39:1996;1372-1382.
13. Line B.R., Cran P., Lazewatsky J., Barett J.A., Cloutier D., Kagan M., Lukasiewcz R., Holmes R.A. Phase I trial of DMP-444, a new thrombus imaging agent. J Nucl Med. 37:1996;117P.
14. Barrett J.A., Crocker A.C., Damphousse D.J., Heminway S.J., Liu S., Edwards D.S., Lazewatsky J.L.et al. Biological evaluation of thrombus imaging agents utilizing water soluble phosphines and tricine as coligands when used to label a hydrazinonicotinamide-modified cyclic glycoprotein IIb/IIIa receptor antagonist with 99mTc. Bioconjugate Chem. 8(2):1997;155-160.
15. Mosher D.F. Physiology of thrombospondin. Ann Rev Med. 41:1990;85-97.
16. Mosher D.F., Doyle M.F., Jaffe E.A. Synthesis and secretion of thrombospondin by cultured human endothelial cells. J Cell Biol. 93:1982;343-348.
17. Lawler J. The structural and functional properties of thrombospondin. Blood. 67:1986;1197-1209.
18. Silverstein R.L., Leung L.L., Nachman R.L. Thrombospondin. A versatile multifunctional glycoprotein Arteriosclerosis. 6:1986;245-253.
19. Frazier W.A. Thrombospondin. A modular adhesive glycoprotein of platelets and nucleated cells J Cell Biol. 105:1986;625-632.
20. Asch A.S., Nachman R.L. Thrombospondin. Phenomenology to function Prog Hemostasis Thromb. 9:1989;157-176.
21. Mosher D.F., Pesciotta D.M., Loftus J.C., Albrecht R.M. Secreted alpha granule proteins. The race for receptors George J.N., Nurden A.T., Phillipps D.R. Platelet Membrane Glycoproteins. 1985;171-191 Plenum, New York.
22. Boukerche H., McGregor J.L. Characterization of an antithrombospondin monoclonal antibody (P8) that inhibits human blood platelet functions. Normal binding of P8 to thrombin activated Glanzmann thrombasthenic platelets. Eur J Biochem. 171:1988;383-392.
23. Legrand C., Dubernard V., Kieffer N., Nurden A.T. Use of a monoclonal antibody to measure the surface expression of thrombospondin following platelet activation. Eur J Biochem. 171:1988;393-399.
24. Kieffer N., Nurden A.T., Hasitz M., Titeux M., Breton-Gorius J. Identification of platelet membrane thrombospondin binding molecules using an anti-thrombospondin antibody. Biochim Biophys Acta. 967(3):1988;408-415.
25. McGregor J.L., Catimel B., Parmentier S., Clezardin P., Dechavanne M., Leung L.L. Rapid purification and partial characterization of human platelet glycoprotein IIIb. Interaction with thrombospondin and its role in platelet aggregation. J Biol Chem. 264(1):1989;501-506.
26. Murphy-Ullrich J.E., Mosher D.F. Localization of thrombospondin in clots formed in situ. Blood. 66:1985;1098-1104.
27. Tuszynski G.P., Rothman V.L., Murphy A., Siegler K., Smith L., Smith S., Karczewski J., Knudsen K.A. Thrombospondin promotes cell-substratum adhesion. Science. 236:1987;1570-1573.
28. Raugi G.J., Olreud J.E., Gown A.M. Thrombospondin in early human wound tissue. J Invest Dermatol. 89:1987;551-554.
29. Tuszynski G.P., Rothman V.L., Deutch A.H., Hamilton B.K., Eyal J. Biological activities of peptides and peptide analogues derived from common sequences present in thrombospondin, properdin and malarial proteins. J Cell Biol. 116:1992;209-217.
30. Thakur M.L., Kolan H., Li J., Wiaderkiewicz R., Pallela V.R., Duggaraju R., Schally A.V. Radiolabeled somatostatin analogs in prostate cancer. Nucl Med Biol. 24:1997;105-113.
31. Pallela VR, Thakur ML, Chakder S, and Rattan S. Tc-99m labeled VIP receptor agonist: Functional studies. J Nucl Med. In Press 1999.
32. Leadley R.J., Humphrey W.R., Erickson L.A., Shebuski R.J. Inhibition of thrombus formation by endothelin-1 in canine models of arterial thrombosis. Thromb Haemost. 74:1995;1583-1590.
33. Dorfman G.S. Percutaneous inferior vena cava filters. Radiology. 174:1990;987-992.
34. Joist J.H., Baker R.K., Thakur M.L., Welch M.J. Indium-111 labeled platelets. Uptake and loss of label and in vitro function of labelled platelets J Lab Clin Med. 92:1978;829-836.
35. Nicosia R.F., Tuszynski G.P. Matrix-bound thrombospondin promotes angiogenesis in vitro. J Cell Biol. 124:1994;183-193.
36. Wang T.N., Qian X.H., Granick M.S., Solomon M.P., Rothman V.L., Tuszynski G.P. The effect of thrombospondin on oral squamous carcinoma cell invasion of collagen. Am J Surg. 170(5):1995;502-505.
37. Thakur M.L., Pallela V.R., Consigny P.M. Tc-99m-TP 1201 for imaging thromboembolism. Radiology. 205:1997;267P.
38. Pallela VR, Consigny PM, Shi R, Thakur ML. Imaging vascular thrombosis with Tc-99m-TP 1300 peptide derived from active domain of thrombospondin. 1998;39:64P.
39. Pallela V.R., Consigny P.M., Shi R., Thakur M.L. Tc-99m-labeled Fibrin-α-chain peptide analog for imaging vascular thrombosis. Eur J Nucl Med. 25:1998;1170.